•The European Commission authorized an expanded label for VENCLYXTO to include new combination therapies for previously untreated chronic lymphocytic leukemia patients.
•UnitedHealth's insurance unit announced it will eliminate prior approval requirements for about two-thirds of healthcare services for members under age 18.